Pentobarbital sodium
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Pentobarbital Sodium is a prescription injectable solution (50 mg/mL) used for intramuscular or intravenous administration. Manufactured by Hikma Pharmaceuticals USA Inc., it's a DEA Schedule II controlled substance for medical purposes like sedation or anesthesia. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Pentobarbital sodium
Access the FDA dataset for Pentobarbital sodium — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025